daunorubicin has been researched along with transforming growth factor beta in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloch, A | 1 |
| Egawa, K; Seo, N; Takigawa, M; Tokura, Y | 1 |
| Gaidarova, S; Jiménez, SA | 1 |
| Song, J; Yang, Y; Zhao, S | 1 |
4 other study(ies) available for daunorubicin and transforming growth factor beta
| Article | Year |
|---|---|
Dynamics of interaction between DNA-specific antitumor agents and serum-contained cytokines in the initiation of ML-1 human myeloblastic leukemia cell differentiation.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Differentiation; Cytarabine; Cytokines; Dactinomycin; Daunorubicin; DNA, Neoplasm; Drug Synergism; Humans; Leukemia, Myeloid, Acute; Monocytes; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1993 |
Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; Antibody Specificity; Carcinoma, Hepatocellular; Cytokines; Cytotoxicity, Immunologic; Daunorubicin; Interleukin-10; Killer Cells, Natural; Lymphocyte Depletion; Lymphocytes, Tumor-Infiltrating; Male; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Receptors, Antigen, T-Cell, gamma-delta; Suppressor Factors, Immunologic; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic; Transforming Growth Factor beta; Tumor Cells, Cultured | 1999 |
Inhibition of basal and transforming growth factor-beta-induced stimulation of COL1A1 transcription by the DNA intercalators, mitoxantrone and WP631, in cultured human dermal fibroblasts.
Topics: Antineoplastic Agents; Apoptosis; Cell Survival; Cells, Cultured; Collagen; Collagen Type I; Collagen Type I, alpha 1 Chain; Daunorubicin; Dermis; Fibroblasts; Fibronectins; Humans; Intercalating Agents; Mitoxantrone; Promoter Regions, Genetic; Protein Binding; RNA Stability; Sp1 Transcription Factor; Transcription, Genetic; Transforming Growth Factor beta | 2002 |
Caspase-dependent apoptosis and -independent poly(ADP-ribose) polymerase cleavage induced by transforming growth factor beta1.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Caspases; Cell Line; Cell Separation; Cycloheximide; Daunorubicin; DNA Fragmentation; Enzyme Inhibitors; Flow Cytometry; Hepatocytes; Immunoblotting; Mice; Microscopy, Fluorescence; Poly(ADP-ribose) Polymerases; Protein Kinase C; Protein Kinase C-delta; Protein Synthesis Inhibitors; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |